{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-033579","form_type":"8-K","ticker":"CLDI","cik":"0001855485","company_name":"Calidi Biotherapeutics, Inc.","filed_at":"2024-08-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.960085+00:00","generated_at":"2026-05-31T08:07:18.588095+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"low","headline":"Calidi Biotherapeutics posts presentation on new wholly owned subsidiary Redtail Biopharma","bullets":["Presentation made available August 22, 2024 on company website.","Redtail Biopharma, Inc. is a new wholly owned subsidiary of Calidi Biotherapeutics.","No financial terms or strategic details disclosed in the 8-K or presentation excerpt."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-033579","json":"https://secwatch.observer/filing/0001493152-24-033579.json","markdown":"https://secwatch.observer/filing/0001493152-24-033579.md","text":"https://secwatch.observer/filing/0001493152-24-033579.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855485/000149315224033579/0001493152-24-033579-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855485/000149315224033579/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:07:18.588095+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}